Cite
HARVARD Citation
Hansen, A. et al. (2017). Determinants of the recommended phase 2 dose of molecular targeted agents. Cancer. 123 (8), pp. 1409-1415. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hansen, A. et al. (2017). Determinants of the recommended phase 2 dose of molecular targeted agents. Cancer. 123 (8), pp. 1409-1415. [Online].